Ocugen (OCGN) Total Liabilities (2014 - 2026)
Ocugen's (OCGN) quarterly Total Liabilities came in at $51.1 million in Q1 2026, up 5.26% YoY from $48.5 million in Q1 2025, and down 8.23% on a QoQ basis from $55.7 million in Q4 2025.
Ocugen (OCGN) Total Liabilities (2014 - 2026) Analysis & Trends
Ocugen (OCGN) has 13 years of Total Liabilities data on file, last reported at $51.1 million in Q1 2026.
- Quarterly Total Liabilities rose 5.26% year-over-year to $51.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.1 million (up 5.26% YoY) and the FY2025 annual result came in at $55.7 million, up 5.44% from the prior year.
- Total Liabilities retreated to $51.1 million in Q1 2026, from $55.7 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $55.7 million in Q4 2025 to a low of $16.2 million in Q1 2022.
- A 5-year average of $35.0 million and a median of $30.6 million in 2022 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities jumped 248.5% — and 2024, when it sank 31.42%.
- Tracing OCGN's Total Liabilities over 5 years: stood at $34.7 million in 2022, then slumped by 30.79% to $24.0 million in 2023, then surged by 120.2% to $52.8 million in 2024, then gained by 5.44% to $55.7 million in 2025, then declined by 8.23% to $51.1 million in 2026.
- The last three Total Liabilities figures came in at $51.1 million (Q1 2026), $55.7 million (Q4 2025), and $54.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Ocugen | 457.71 Mn | 357.61 Mn | - | 140.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 140.76 Mn |
| Mar 31, 2026 | 51.10 Mn |
| Dec 31, 2025 | 55.68 Mn |
| Sep 30, 2025 | 54.06 Mn |
| Jun 30, 2025 | 50.54 Mn |
| Mar 31, 2025 | 48.55 Mn |
| Dec 31, 2024 | 52.81 Mn |
| Sep 30, 2024 | 21.31 Mn |
| Jun 30, 2024 | 23.62 Mn |
| Mar 31, 2024 | 21.53 Mn |
| Dec 31, 2023 | 23.98 Mn |
| Sep 30, 2023 | 24.89 Mn |
| Jun 30, 2023 | 29.73 Mn |
| Mar 31, 2023 | 31.40 Mn |
| Dec 31, 2022 | 34.65 Mn |
| Sep 30, 2022 | 30.55 Mn |
| Jun 30, 2022 | 23.61 Mn |
| Mar 31, 2022 | 16.21 Mn |
| Dec 31, 2021 | 9.94 Mn |
| Sep 30, 2021 | 9.20 Mn |